Long term MRI follow-up of patients with post infectious encephalomyelitis: evidence for a monophasic disease

被引:41
作者
O'Riordan, JI
Gomez-Anson, B
Moseley, IF
Miller, DH
机构
[1] Inst Neurol, NMR Res Unit, London WC1N 3BG, England
[2] UCL Natl Hosp Neurol & Neurosurg, Lysholm Dept Neuroradiol, London WC1N 3BG, England
关键词
post infectious encephalomyelitis; multiple sclerosis;
D O I
10.1016/S0022-510X(99)00160-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Post infectious encephalomyelitis and multiple sclerosis are both inflammatory demyelinating disorders of the central nervous system. Whereas multiple sclerosis is a multi phasic disease with recurrent episodes disseminated in time and place, post infectious encephalomyelitis is usually considered to be a monophasic illness. This study used serial brain MRI to clarify whether the latter hypothesis holds for the long term. Post infectious encephalomyelitis was defined as the development of a central nervous system white matter disorder occurring in close temporal relationship with a viral, bacterial or other infection. There were eleven patients, mean age at presentation 21 years (4-48), and mean period of follow-up of 8 years (3.5-11). T2-weighted brain MRI was abnormal in all II cases during the acute stages of the illness. On follow-up 6 patients had made a complete clinical recovery, 3 patients had mild residual deficits and one severe neurological deficits necessitating ventilatory support. No patient experienced an exacerbation during the follow-up period. MRI revealed complete resolution of abnormalities in 3 and partial resolution in 7; new white matter lesions were seen in only one patient. This long term follow-up study suggests that there is a definable group with post infectious encephalomyelitis who exhibit a monophasic clinical and MRI pattern in the long term. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:132 / 136
页数:5
相关论文
共 27 条
[1]  
[Anonymous], 1959, ALLERGIC ENCEPHALOMY
[2]   MR DIAGNOSIS OF ACUTE DISSEMINATED ENCEPHALOMYELITIS [J].
ATLAS, SW ;
GROSSMAN, RI ;
GOLDBERG, HI ;
HACKNEY, DB ;
BILANIUK, LT ;
ZIMMERMAN, RA .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1986, 10 (05) :798-801
[3]   Inflammatory central nervous system demyelination: Correlation of magnetic resonance imaging findings with lesion pathology [J].
Bruck, W ;
Bitsch, A ;
Kolenda, H ;
Bruck, Y ;
Stiefel, M ;
Lassmann, H .
ANNALS OF NEUROLOGY, 1997, 42 (05) :783-793
[4]  
CAMPI A, 1995, AM J NEURORADIOL, V16, P115
[5]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[6]   LONG-TERM FOLLOW-UP OF ACUTE PARTIAL TRANSVERSE MYELOPATHY [J].
FORD, B ;
TAMPIERI, D ;
FRANCIS, G .
NEUROLOGY, 1992, 42 (01) :250-252
[7]   MRI, VEP, SEP AND BIOTHESIOMETRY SUGGEST MONOSYMPTOMATIC ACUTE OPTIC NEURITIS TO BE A 1ST MANIFESTATION OF MULTIPLE-SCLEROSIS [J].
FREDERIKSEN, JL ;
LARSSON, HBW ;
OLESEN, J ;
STIGSBY, B .
ACTA NEUROLOGICA SCANDINAVICA, 1991, 83 (05) :343-350
[8]   Stepwise syntheses of core-modified, meso-substituted porphyrins [J].
Heo, PY ;
Shin, K ;
Lee, CH .
TETRAHEDRON LETTERS, 1996, 37 (02) :197-200
[9]   CLINICAL AND MAGNETIC-RESONANCE-IMAGING IN OPTIC NEURITIS [J].
JACOBS, L ;
MUNSCHAUER, FE ;
KABA, SE .
NEUROLOGY, 1991, 41 (01) :15-19
[10]   Intramuscular interferon beta-1 alpha for disease progression in relapsing multiple sclerosis [J].
Jacobs, LD ;
Cookfair, DL ;
Rudick, RA ;
Herndon, RM ;
Richert, JR ;
Salazar, AM ;
Fischer, JS ;
Goodkin, DE ;
Granger, CV ;
Simon, JH ;
Alam, JJ ;
Bartoszak, DM ;
Bourdette, DN ;
Braiman, J ;
Brownscheidle, CM ;
Coats, ME ;
Cohan, SL ;
Dougherty, DS ;
Kinkel, RP ;
Mass, MK ;
Munschauer, FE ;
Priore, RL ;
Pullicino, PM ;
Scherokman, BJ ;
WeinstockGuttman, B ;
Whitman, RH ;
Baird, WC ;
Fillmore, M ;
Bona, LM ;
ColonRuiz, ME ;
Nadine, BS ;
Donovan, A ;
Bennett, S ;
Kieffer, YM ;
Umhauer, MA ;
Miller, CE ;
Kilic, AK ;
Sargent, EL ;
Schachter, M ;
Shucard, DW ;
Weider, V ;
Catalano, BA ;
Cervi, JM ;
Czekay, C ;
Farrell, JL ;
Filippini, JS ;
Matyas, RC ;
Michienzi, KE ;
Ito, M ;
OMalley, JA .
ANNALS OF NEUROLOGY, 1996, 39 (03) :285-294